Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$101,474,000
+$22,939,000 QoQ
Shares Held
5,650,000
0.0% QoQ
Ownership
5.07%
of shares outstanding
% of Portfolio
6.09%
of 13F equity value
Holder Rank
#5
of 207 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Commodore Capital LP holds $258,674,000 across 2 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (39.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
3,000,000 | $157,200,000 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
5,650,000 | $101,474,000 |
All Filings in AMLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,474,000 | 5,650,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $78,535,000 | 5,650,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $68,252,000 | 5,650,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $55,385,746 | 4,075,478 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||